Literature DB >> 17332506

The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.

Rosa A Cardone1, Antonia Bellizzi, Giovanni Busco, Edward J Weinman, Maria E Dell'Aquila, Valeria Casavola, Amalia Azzariti, Anita Mangia, Angelo Paradiso, Stephan J Reshkin.   

Abstract

Understanding the signal transduction systems governing invasion is fundamental for the design of therapeutic strategies against metastasis. Na(+)/H(+) exchanger regulatory factor (NHERF1) is a postsynaptic density 95/disc-large/zona occludens (PDZ) domain-containing protein that recruits membrane receptors/transporters and cytoplasmic signaling proteins into functional complexes. NHERF1 expression is altered in breast cancer, but its effective role in mammary carcinogenesis remains undefined. We report here that NHERF1 overexpression in human breast tumor biopsies is associated with metastatic progression, poor prognosis, and hypoxia-inducible factor-1alpha expression. In cultured tumor cells, hypoxia and serum deprivation increase NHERF1 expression, promote the formation of leading-edge pseudopodia, and redistribute NHERF1 to these pseudopodia. This pseudopodial localization of NHERF1 was verified in breast biopsies and in three-dimensional Matrigel culture. Furthermore, serum deprivation and hypoxia stimulate the Na(+)/H(+) exchanger, invasion, and activate a protein kinase A (PKA)-gated RhoA/p38 invasion signal module. Significantly, NHERF1 overexpression was sufficient to induce these morphological and functional changes, and it potentiated their induction by serum deprivation. Functional experiments with truncated and binding groove-mutated PDZ domain constructs demonstrated that NHERF1 regulates these processes through its PDZ2 domain. We conclude that NHERF1 overexpression enhances the invasive phenotype in breast cancer cells, both alone and in synergy with exposure to the tumor microenvironment, via the coordination of PKA-gated RhoA/p38 signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332506      PMCID: PMC1855021          DOI: 10.1091/mbc.e06-07-0617

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  60 in total

1.  Generation of a functional mammary gland from a single stem cell.

Authors:  Mark Shackleton; François Vaillant; Kaylene J Simpson; John Stingl; Gordon K Smyth; Marie-Liesse Asselin-Labat; Li Wu; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

2.  AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer.

Authors:  Jose V Moyano; Joseph R Evans; Feng Chen; Meiling Lu; Michael E Werner; Fruma Yehiely; Leslie K Diaz; Dmitry Turbin; Gamze Karaca; Elizabeth Wiley; Torsten O Nielsen; Charles M Perou; Vincent L Cryns
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 3.  New signals from the invasive front.

Authors:  Gerhard Christofori
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 4.  Hypoxia signalling in cancer and approaches to enforce tumour regression.

Authors:  Jacques Pouysségur; Frédéric Dayan; Nathalie M Mazure
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 5.  The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature.

Authors:  Salvador Harguindey; Gorka Orive; José Luis Pedraz; Angelo Paradiso; Stephan J Reshkin
Journal:  Biochim Biophys Acta       Date:  2005-09-25

Review 6.  HIFs, hypoxia, and vascular development.

Authors:  Kelly L Covello; M Celeste Simon
Journal:  Curr Top Dev Biol       Date:  2004       Impact factor: 4.897

7.  Rho/ROCK-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 MAPK in tumour cells exhibiting autocrine c-Met activation.

Authors:  Zongjian Jia; Julie Vadnais; Michael L Lu; Josette Noël; Ivan R Nabi
Journal:  Biol Cell       Date:  2006-06       Impact factor: 4.458

8.  BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.

Authors:  S Tommasi; A Crapolicchio; R Lacalamita; M Bruno; A Monaco; S Petroni; F Schittulli; S Longo; M Digennaro; D Calistri; A Mangia; Angelo Paradiso
Journal:  Mutat Res       Date:  2005-07-18       Impact factor: 2.433

9.  Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.

Authors:  Andreas Wicki; François Lehembre; Nikolaus Wick; Brigitte Hantusch; Dontscho Kerjaschki; Gerhard Christofori
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

10.  The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors.

Authors:  Weigang Wang; Ghassan Mouneimne; Mazen Sidani; Jeffrey Wyckoff; Xiaoming Chen; Anastasia Makris; Sumanta Goswami; Anne R Bresnick; John S Condeelis
Journal:  J Cell Biol       Date:  2006-05-01       Impact factor: 10.539

View more
  63 in total

1.  Novel bioactivity of NHERF1 in corneal neovascularization.

Authors:  Peng Chen; Ye Wang; Lingling Yang; Changyou Li; Yao Wang; Lixin Xie; Yiqiang Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-10       Impact factor: 3.117

2.  Effect of NHE1 antisense gene transfection on the biological behavior of SGC-7901 human gastric carcinoma cells.

Authors:  Hai-Feng Liu; Xiao-Chun Teng; Jing-Chen Zheng; Gang Chen; Xing-Wei Wang
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.

Authors:  Antonia Bellizzi; Andrea Malfettone; Rosa A Cardone; Anita Mangia
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

Review 4.  New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Authors:  Adrienne M Bushau-Sprinkle; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

5.  High capacity Na+/H+ exchange activity in mineralizing osteoblasts.

Authors:  Li Liu; Paul H Schlesinger; Nicole M Slack; Peter A Friedman; Harry C Blair
Journal:  J Cell Physiol       Date:  2011-06       Impact factor: 6.384

6.  Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation.

Authors:  Laura Fouassier; Peter Rosenberg; Martine Mergey; Bruno Saubaméa; Audrey Clapéron; Nils Kinnman; Nicolas Chignard; Gunilla Jacobsson-Ekman; Birgitta Strandvik; Colette Rey; Véronique Barbu; Rolf Hultcrantz; Chantal Housset
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

7.  Human mesenchymal stem cells induce E-cadherin degradation in breast carcinoma spheroids by activating ADAM10.

Authors:  Angela Dittmer; Kristina Hohlfeld; Jana Lützkendorf; Lutz P Müller; Jürgen Dittmer
Journal:  Cell Mol Life Sci       Date:  2009-07-15       Impact factor: 9.261

8.  Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium.

Authors:  Mary Brown; Djanybek Adyshev; Vytautus Bindokas; Jaideep Moitra; Joe G N Garcia; Steven M Dudek
Journal:  Microvasc Res       Date:  2010-01-04       Impact factor: 3.514

9.  Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.

Authors:  D S Wheeler; S R Barrick; M J Grubisha; A M Brufsky; P A Friedman; G Romero
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

10.  A dialogue between the hypoxia-inducible factor and the tumor microenvironment.

Authors:  Frédéric Dayan; Nathalie M Mazure; M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.